Thursday, November 26, 2020 10:15:18 PM
Medical systems and methods for treating kidney disease alone, heart failure alone, chronic kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a natriuretic peptide such as Vessel Dilator to a subject. Methods for increasing and maintaining peptide levels at a certain concentration include direct peptide delivery via either an external or implantable programmable pump.
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=17&p=1&f=G&l=50&d=PG01&S1=Capricor&OS=Capricor&RS=Capricor
Never buy or sell based on my posts.Always consult with a licensed securities professional before you buy or sell any security.My posts are opinions only.Never use them as due diligence.My positions are subject to change without notice.
Recent CAPR News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/17/2024 08:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 10:01:22 AM
- Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock • GlobeNewswire Inc. • 10/17/2024 10:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/17/2024 04:15:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/16/2024 08:35:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:25:24 PM
- Capricor Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 10/16/2024 08:17:48 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/16/2024 05:31:08 PM
- Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress • GlobeNewswire Inc. • 10/11/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 01:16:15 PM
- Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 10/09/2024 01:15:00 PM
- Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress • GlobeNewswire Inc. • 10/04/2024 01:15:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/24/2024 08:03:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:01:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 08:01:08 PM
- Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy • GlobeNewswire Inc. • 09/24/2024 12:00:00 PM
- Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024 • GlobeNewswire Inc. • 09/23/2024 01:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 01:15:10 PM
- Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 09/17/2024 01:15:00 PM
- Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences • GlobeNewswire Inc. • 09/06/2024 12:30:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/23/2024 08:01:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 01:00:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:00:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:06:46 PM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM